Menu

TS Picks: April 3, 2017

USDA posting few animal inspections; HHS secretary proposes cutting indirect research expenses; science journalism vs. fake news

Apr 3, 2017
Bob Grant

UNITED STATES CONGRESS, DISTRICT OFFICE OF TOM PRICE

Selections from The Scientist’s reading list:
 

  • After last month’s revelation that the US Department of Agriculture (USDA) would no longer publicly list its animal welfare inspection reports and enforcement actions, the situation seems to have changed, slightly. According to Science, the USDA has posted four reports—from inspections conducted on January 10, 12, and 17 of this year—during the first quarter of 2017. The USDA has not posted any such reports since Donald Trump was inaugurated on January 20, but the agency told Science that it has inspected “about 300” animal research facilities between the start of 2017 until March 30.
     
  • Proposed cuts to the budget of the National Institutes of Health (NIH) may impact the overhead costs covered by many agency grants. Tom Price, secretary of the US Department of Health and Human Services, told Congress last week that “indirect expenses,” such as electric bills, lab equipment, and other overhead costs, may be on the chopping block if the Trump administration’s cuts are preserved as legislatures craft a federal budget. Science advocates are warning against such a move. “The reality is we don’t have other revenue sources to pay for those things, because let’s face it, we are not going to rob tuition to pay for those costs,” Tobin Smith, vice president for policy at the Association of American Universities, told The Chronicle of Higher Education. “It just is not going to happen.”
     
  • Stephen Metcalfe, chair of the U.K.’s House of Commons Science and Technology Select Committee, wrote last week in The Guardian that responsible science journalism is more important now than ever. “If the press is to maintain the public’s trust, journalists must demonstrate their commitment to clear and unbiased reporting of scientific facts,” he wrote, “and be given the necessary support by policymakers to do so.” Metcalfe cited reporting on the absence of a link between the MMR vaccine and autism, genetically modified foods, and climate change as examples where accurate science reporting has sometimes yielded to the economic pressures of the news business. Referring to a new report from his committee, he decried the ease with which UK policymakers can cherry pick scientific information gleaned from the press. “My committee found that the rules around policymaking currently make it far too easy for ministers to use science selectively to either back a political aim or, worse still, to mask financial reasons for not taking sufficient action,” Metcalfe wrote. “We need a firm commitment by all those in the political sphere to pursue evidence-based policy making, rather than policy-based evidence.”

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.